Home | Founder | What's New | In The News | Consulting | |||||||
H1N1 Consulting Paradigm Shift Intervention Monitoring |
Audio:Aug9
Aug18
Sep5
Sep15
twitter
Commentary CDC
Hopes and Dreams On 2011 trH3N2 Swine Link The above comment is also in the latest CDC “Have You Heard” and is also in the “Hopes and Dreams” category. The data is created by a strong bias in trH3N2 testing, which is done solely by the CDC and almost exclusively on samples from cases with a close proximity to swine. So far this year, the CDC has not provided any evidence for trH3N2 infection in any swine in close proximity to the five confirmed trH3N2 cases, and there have been no reports by any agency on swine infected with the constellation of genes found in all of the five confirmed 2011 trH3N2 cases. The above mantra has been repeated so many times that other agencies, such as the Maine CDC misstated the history of the 2011 trH3N2 cases, claiming all have been exposed to swine, which is not true for the Indiana case (2M) who was exposed to a caretaker with swine exposure. However neither the caretaker nor the associated swine were symptomatic and none have been reported to have been infected wit SOIV, trH3N2, or trH3N2 with the constellation found in the Indiana and Pennsylvania cases. Moreover, the CDC has classified the Indiana case as limited human to human transmission. The misstatement in the Maine advisory has been propagated by various media outlets, as well as ProMED, which is widely read by media reporters. The CDC testing for trH3N2 is dependent on receipt of appropriate samples from state labs, but identification of trH3N2 samples is problematic because the H3 is from a seasonal H3N2 infection of swine in the 1990’s. Consequently, 2010 trH3N2 isolates like A/Pennsylvania/40/2010 were reported 5 months after infection because of initial designation as seasonal H3N2. The recent isolate from Maine, A/Maine/06/2011 was inconclusive in serotype testing, while more evolved isolates, like A/Pennsylvania/09/2011 were designated unsubtypables because the sample was influenza A positve, but H3 negative because it had evolved away from the original human H3 sequences. However, the subtyping data can be unreliable. The four H3 sequences from Indiana and Pennsylvania were very closely related to each other, but only two were listed in the sub-typing table and figure in the CDC’s FluView (for weeks 33 and 34). However, the reporting of these two cases was inconsistent, appearing in reports for weeks 35 and 36, disappearing win reports for weeks 37 and 38, reappearing in week 39, and disappearing in week 40. Moreover the week 39 table reported both unsubtypables, while the figure based on the table only reported the week 33 cases. These weekly fluctuations for these two samples suggest criteria for calling samples unsubtypable were in a constent state of flux, and the other two trH3N2 were not listed in the table or figures for any of the FluView reports. In addition to the variations for the known trH3N2 cases, undercounts are created through a lack of testing. The majority (67) of the 107 influenza A positive cases reported for the last 10 weeks of the 2010/2011 season (weeks 30-39), so it is unlikely that these samples were sent to the CDC, especially since the MMWR report on the Indiana and Pennsylvania cases requested samples from cases with swine exposure, which may have led to the identification of the case in Maine, since he had attended an agricultural fair, and the sub-typing data was inclusive. The absence of a swine lin would have probably limited additional testing, which is only done by the CDC. The absence of the PCR swine H3 from state labs has severely impacted the detectio of trH3N2 cases, especially those without swine contact. Thus, these tests should be distributed to sate labs, and aggressive testing of influenza A positive samples should be implemented, regardless of swine exposure. Recombinomics
Presentations |
||||||||||
|
Webmaster:
webmaster@recombinomics.com
© 2011
Recombinomics. All
rights
reserved.